Advanced Biomed (ADVB) Net Income towards Common Stockholders (2023 - 2026)
Advanced Biomed (ADVB) posted Net Income towards Common Stockholders of -$144257.0 for Q4 2025, up 62.71% sequentially from -$386901.0 in Q3 2025, and up 56.07% YoY from -$92428.5 in Q4 2024.
Advanced Biomed (ADVB) Net Income towards Common Stockholders (2023 - 2026) Analysis & Trends
Advanced Biomed has reported Net Income towards Common Stockholders for 3 years, with the latest figure at -$144257.0 in Q4 2025.
- Quarterly Net Income towards Common Stockholders rose 56.07% year-over-year to -$144257.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 27.57% YoY) and the FY2025 annual result came in at -$3.3 million, down 17.13% from the prior year.
- Net Income towards Common Stockholders advanced to -$144257.0 in Q4 2025 per ADVB's latest filing, from -$386901.0 in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$144257.0 in Q4 2025 and troughed at -$1.5 million in Q2 2025.
- A 3-year average of -$535483.1 and a median of -$328410.0 in 2024 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders tumbled 125.95% in 2024, then soared 82.35% in 2025.
- Over 3 years, Net Income towards Common Stockholders stood at -$145345.0 in 2023, then sank by 125.95% to -$328410.0 in 2024, then soared by 56.07% to -$144257.0 in 2025.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$144257.0, -$386901.0, and -$1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Advanced Biomed | 12.28 Mn | 12.28 Mn | - | -488,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -488,942.00 |
| Dec 31, 2025 | 6.86 Mn |
| Sep 30, 2025 | -386,901.00 |
| Jun 30, 2025 | -1.50 Mn |
| Mar 31, 2025 | -1.38 Mn |
| Dec 31, 2024 | -907,904.00 |
| Sep 30, 2024 | -265,580.00 |
| Jun 30, 2024 | -809,386.00 |
| Mar 31, 2024 | -1.06 Mn |
| Dec 31, 2023 | -145,345.00 |